JP2017501136A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017501136A5 JP2017501136A5 JP2016535121A JP2016535121A JP2017501136A5 JP 2017501136 A5 JP2017501136 A5 JP 2017501136A5 JP 2016535121 A JP2016535121 A JP 2016535121A JP 2016535121 A JP2016535121 A JP 2016535121A JP 2017501136 A5 JP2017501136 A5 JP 2017501136A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- cells
- peptide
- ser
- hydrogel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004027 cell Anatomy 0.000 claims 33
- 239000000017 hydrogel Substances 0.000 claims 23
- 108090000765 processed proteins & peptides Proteins 0.000 claims 22
- 239000000816 peptidomimetic Substances 0.000 claims 19
- 238000000034 method Methods 0.000 claims 18
- 235000001014 amino acid Nutrition 0.000 claims 16
- 229940024606 amino acid Drugs 0.000 claims 16
- 210000000130 stem cell Anatomy 0.000 claims 16
- 150000001413 amino acids Chemical class 0.000 claims 12
- 238000001879 gelation Methods 0.000 claims 12
- 150000008575 L-amino acids Chemical class 0.000 claims 10
- 239000003431 cross linking reagent Substances 0.000 claims 8
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims 7
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 7
- -1 aliphatic D- Chemical class 0.000 claims 7
- 150000001875 compounds Chemical class 0.000 claims 7
- 210000002308 embryonic cell Anatomy 0.000 claims 6
- 238000001338 self-assembly Methods 0.000 claims 6
- 125000001931 aliphatic group Chemical group 0.000 claims 5
- 210000004263 induced pluripotent stem cell Anatomy 0.000 claims 5
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims 4
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims 4
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims 4
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims 4
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 4
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims 4
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims 4
- 239000004472 Lysine Substances 0.000 claims 4
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims 4
- 235000018977 lysine Nutrition 0.000 claims 4
- 229920000642 polymer Polymers 0.000 claims 4
- 125000006239 protecting group Chemical group 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- OGNSCSPNOLGXSM-UHFFFAOYSA-N 2,4-diaminobutyric acid Chemical compound NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 3
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 3
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 claims 3
- 206010028980 Neoplasm Diseases 0.000 claims 3
- 230000002378 acidificating effect Effects 0.000 claims 3
- 230000000975 bioactive effect Effects 0.000 claims 3
- 210000004899 c-terminal region Anatomy 0.000 claims 3
- 201000011510 cancer Diseases 0.000 claims 3
- 230000007423 decrease Effects 0.000 claims 3
- 210000002919 epithelial cell Anatomy 0.000 claims 3
- 210000002950 fibroblast Anatomy 0.000 claims 3
- 210000003958 hematopoietic stem cell Anatomy 0.000 claims 3
- 210000002569 neuron Anatomy 0.000 claims 3
- 239000013610 patient sample Substances 0.000 claims 3
- 238000007639 printing Methods 0.000 claims 3
- 239000000243 solution Substances 0.000 claims 3
- 230000000638 stimulation Effects 0.000 claims 3
- PECYZEOJVXMISF-UHFFFAOYSA-N 3-aminoalanine Chemical compound [NH3+]CC(N)C([O-])=O PECYZEOJVXMISF-UHFFFAOYSA-N 0.000 claims 2
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims 2
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 claims 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims 2
- NUXSIDPKKIEIMI-LURJTMIESA-N N(6)-carboxymethyl-L-lysine Chemical compound OC(=O)[C@@H](N)CCCCNCC(O)=O NUXSIDPKKIEIMI-LURJTMIESA-N 0.000 claims 2
- 108091034117 Oligonucleotide Proteins 0.000 claims 2
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 claims 2
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 claims 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 2
- 239000004473 Threonine Substances 0.000 claims 2
- 235000009582 asparagine Nutrition 0.000 claims 2
- 229960001230 asparagine Drugs 0.000 claims 2
- 235000003704 aspartic acid Nutrition 0.000 claims 2
- 230000003796 beauty Effects 0.000 claims 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 2
- 235000018417 cysteine Nutrition 0.000 claims 2
- 235000013922 glutamic acid Nutrition 0.000 claims 2
- 239000004220 glutamic acid Substances 0.000 claims 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims 2
- 235000004554 glutamine Nutrition 0.000 claims 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims 2
- 238000002347 injection Methods 0.000 claims 2
- 239000007924 injection Substances 0.000 claims 2
- 229930182817 methionine Natural products 0.000 claims 2
- 235000006109 methionine Nutrition 0.000 claims 2
- 229960003104 ornithine Drugs 0.000 claims 2
- 230000004962 physiological condition Effects 0.000 claims 2
- 235000004400 serine Nutrition 0.000 claims 2
- 239000004055 small Interfering RNA Substances 0.000 claims 2
- 235000008521 threonine Nutrition 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 2
- BEWCSNDRHAIGAY-BYPYZUCNSA-N (2s)-2-amino-4-methyltellanylbutanoic acid Chemical compound C[Te]CC[C@H](N)C(O)=O BEWCSNDRHAIGAY-BYPYZUCNSA-N 0.000 claims 1
- JFOWDKWFHZIMTR-RUCXOUQFSA-N (2s)-2-aminopentanedioic acid;(2s)-2,5-diamino-5-oxopentanoic acid Chemical compound OC(=O)[C@@H](N)CCC(N)=O.OC(=O)[C@@H](N)CCC(O)=O JFOWDKWFHZIMTR-RUCXOUQFSA-N 0.000 claims 1
- OECHUGCITYQGCY-YUMQZZPRSA-N (2s)-5-amino-2-[[(2s)-2,5-diaminopentanoyl]amino]pentanoic acid Chemical compound NCCC[C@H](N)C(=O)N[C@H](C(O)=O)CCCN OECHUGCITYQGCY-YUMQZZPRSA-N 0.000 claims 1
- UKAUYVFTDYCKQA-UHFFFAOYSA-N -2-Amino-4-hydroxybutanoic acid Natural products OC(=O)C(N)CCO UKAUYVFTDYCKQA-UHFFFAOYSA-N 0.000 claims 1
- NPSWHDAHNWWMEG-UHFFFAOYSA-N 2-aminohex-5-enoic acid Chemical compound OC(=O)C(N)CCC=C NPSWHDAHNWWMEG-UHFFFAOYSA-N 0.000 claims 1
- SCGJGNWMYSYORS-UHFFFAOYSA-N 2-azaniumylhex-5-ynoate Chemical compound OC(=O)C(N)CCC#C SCGJGNWMYSYORS-UHFFFAOYSA-N 0.000 claims 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 239000004475 Arginine Substances 0.000 claims 1
- RJUHZPRQRQLCFL-IMJSIDKUSA-N Asn-Asn Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(O)=O RJUHZPRQRQLCFL-IMJSIDKUSA-N 0.000 claims 1
- HZYFHQOWCFUSOV-IMJSIDKUSA-N Asn-Asp Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(O)=O HZYFHQOWCFUSOV-IMJSIDKUSA-N 0.000 claims 1
- QCWJKJLNCFEVPQ-WHFBIAKZSA-N Asn-Gln Chemical compound NC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O QCWJKJLNCFEVPQ-WHFBIAKZSA-N 0.000 claims 1
- IIFDPDVJAHQFSR-WHFBIAKZSA-N Asn-Glu Chemical compound NC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O IIFDPDVJAHQFSR-WHFBIAKZSA-N 0.000 claims 1
- SONUFGRSSMFHFN-IMJSIDKUSA-N Asn-Ser Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(O)=O SONUFGRSSMFHFN-IMJSIDKUSA-N 0.000 claims 1
- VBKIFHUVGLOJKT-FKZODXBYSA-N Asn-Thr Chemical compound C[C@@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)N)O VBKIFHUVGLOJKT-FKZODXBYSA-N 0.000 claims 1
- VGRHZPNRCLAHQA-IMJSIDKUSA-N Asp-Asn Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(O)=O VGRHZPNRCLAHQA-IMJSIDKUSA-N 0.000 claims 1
- FRYULLIZUDQONW-IMJSIDKUSA-N Asp-Asp Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(O)=O FRYULLIZUDQONW-IMJSIDKUSA-N 0.000 claims 1
- GSMPSRPMQQDRIB-WHFBIAKZSA-N Asp-Gln Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O GSMPSRPMQQDRIB-WHFBIAKZSA-N 0.000 claims 1
- CKAJHWFHHFSCDT-WHFBIAKZSA-N Asp-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O CKAJHWFHHFSCDT-WHFBIAKZSA-N 0.000 claims 1
- DWBZEJHQQIURML-IMJSIDKUSA-N Asp-Ser Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(O)=O DWBZEJHQQIURML-IMJSIDKUSA-N 0.000 claims 1
- NTQDELBZOMWXRS-IWGUZYHVSA-N Asp-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H](N)CC(O)=O NTQDELBZOMWXRS-IWGUZYHVSA-N 0.000 claims 1
- 241000894006 Bacteria Species 0.000 claims 1
- TULNGKSILXCZQT-IMJSIDKUSA-N Cys-Asp Chemical compound SC[C@H](N)C(=O)N[C@H](C(O)=O)CC(O)=O TULNGKSILXCZQT-IMJSIDKUSA-N 0.000 claims 1
- WXOFKRKAHJQKLT-BQBZGAKWSA-N Cys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CS WXOFKRKAHJQKLT-BQBZGAKWSA-N 0.000 claims 1
- YXQDRIRSAHTJKM-IMJSIDKUSA-N Cys-Ser Chemical compound SC[C@H](N)C(=O)N[C@@H](CO)C(O)=O YXQDRIRSAHTJKM-IMJSIDKUSA-N 0.000 claims 1
- WYVKPHCYMTWUCW-YUPRTTJUSA-N Cys-Thr Chemical compound C[C@@H]([C@@H](C(=O)O)NC(=O)[C@H](CS)N)O WYVKPHCYMTWUCW-YUPRTTJUSA-N 0.000 claims 1
- 108090000695 Cytokines Proteins 0.000 claims 1
- 102000004127 Cytokines Human genes 0.000 claims 1
- 150000008574 D-amino acids Chemical class 0.000 claims 1
- 108020004414 DNA Proteins 0.000 claims 1
- 244000070010 Erythrina variegata Species 0.000 claims 1
- DXJZITDUDUPINW-WHFBIAKZSA-N Gln-Asn Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(O)=O DXJZITDUDUPINW-WHFBIAKZSA-N 0.000 claims 1
- SSHIXEILTLPAQT-WHFBIAKZSA-N Gln-Asp Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(O)=O SSHIXEILTLPAQT-WHFBIAKZSA-N 0.000 claims 1
- LOJYQMFIIJVETK-WDSKDSINSA-N Gln-Gln Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(O)=O LOJYQMFIIJVETK-WDSKDSINSA-N 0.000 claims 1
- OWOFCNWTMWOOJJ-WDSKDSINSA-N Gln-Glu Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(O)=O OWOFCNWTMWOOJJ-WDSKDSINSA-N 0.000 claims 1
- UKKNTTCNGZLJEX-WHFBIAKZSA-N Gln-Ser Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CO)C(O)=O UKKNTTCNGZLJEX-WHFBIAKZSA-N 0.000 claims 1
- TUTIHHSZKFBMHM-WHFBIAKZSA-N Glu-Asn Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(O)=O TUTIHHSZKFBMHM-WHFBIAKZSA-N 0.000 claims 1
- FYYSIASRLDJUNP-WHFBIAKZSA-N Glu-Asp Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(O)=O FYYSIASRLDJUNP-WHFBIAKZSA-N 0.000 claims 1
- KOSRFJWDECSPRO-WDSKDSINSA-N Glu-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(O)=O KOSRFJWDECSPRO-WDSKDSINSA-N 0.000 claims 1
- UQHGAYSULGRWRG-WHFBIAKZSA-N Glu-Ser Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CO)C(O)=O UQHGAYSULGRWRG-WHFBIAKZSA-N 0.000 claims 1
- 239000004471 Glycine Substances 0.000 claims 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims 1
- 206010061246 Intervertebral disc degeneration Diseases 0.000 claims 1
- HHSJMSCOLJVTCX-ZDLURKLDSA-N L-Glutaminyl-L-threonine Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H](N)CCC(N)=O HHSJMSCOLJVTCX-ZDLURKLDSA-N 0.000 claims 1
- QUOGESRFPZDMMT-UHFFFAOYSA-N L-Homoarginine Natural products OC(=O)C(N)CCCCNC(N)=N QUOGESRFPZDMMT-UHFFFAOYSA-N 0.000 claims 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims 1
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 claims 1
- GGLZPLKKBSSKCX-YFKPBYRVSA-N L-ethionine Chemical compound CCSCC[C@H](N)C(O)=O GGLZPLKKBSSKCX-YFKPBYRVSA-N 0.000 claims 1
- QUOGESRFPZDMMT-YFKPBYRVSA-N L-homoarginine Chemical compound OC(=O)[C@@H](N)CCCCNC(N)=N QUOGESRFPZDMMT-YFKPBYRVSA-N 0.000 claims 1
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 claims 1
- UKAUYVFTDYCKQA-VKHMYHEASA-N L-homoserine Chemical compound OC(=O)[C@@H](N)CCO UKAUYVFTDYCKQA-VKHMYHEASA-N 0.000 claims 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 1
- LRQKBLKVPFOOQJ-YFKPBYRVSA-N L-norleucine Chemical compound CCCC[C@H]([NH3+])C([O-])=O LRQKBLKVPFOOQJ-YFKPBYRVSA-N 0.000 claims 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims 1
- NVGBPTNZLWRQSY-UWVGGRQHSA-N Lys-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CCCCN NVGBPTNZLWRQSY-UWVGGRQHSA-N 0.000 claims 1
- YSZNURNVYFUEHC-BQBZGAKWSA-N Lys-Ser Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CO)C(O)=O YSZNURNVYFUEHC-BQBZGAKWSA-N 0.000 claims 1
- ZOKVLMBYDSIDKG-CSMHCCOUSA-N Lys-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCCN ZOKVLMBYDSIDKG-CSMHCCOUSA-N 0.000 claims 1
- 108700011259 MicroRNAs Proteins 0.000 claims 1
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 claims 1
- 108010079855 Peptide Aptamers Proteins 0.000 claims 1
- 108091093037 Peptide nucleic acid Proteins 0.000 claims 1
- RJFAYQIBOAGBLC-BYPYZUCNSA-N Selenium-L-methionine Chemical compound C[Se]CC[C@H](N)C(O)=O RJFAYQIBOAGBLC-BYPYZUCNSA-N 0.000 claims 1
- RJFAYQIBOAGBLC-UHFFFAOYSA-N Selenomethionine Natural products C[Se]CCC(N)C(O)=O RJFAYQIBOAGBLC-UHFFFAOYSA-N 0.000 claims 1
- LTFSLKWFMWZEBD-IMJSIDKUSA-N Ser-Asn Chemical compound OC[C@H](N)C(=O)N[C@H](C(O)=O)CC(N)=O LTFSLKWFMWZEBD-IMJSIDKUSA-N 0.000 claims 1
- VBKBDLMWICBSCY-IMJSIDKUSA-N Ser-Asp Chemical compound OC[C@H](N)C(=O)N[C@H](C(O)=O)CC(O)=O VBKBDLMWICBSCY-IMJSIDKUSA-N 0.000 claims 1
- UJTZHGHXJKIAOS-WHFBIAKZSA-N Ser-Gln Chemical compound OC[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O UJTZHGHXJKIAOS-WHFBIAKZSA-N 0.000 claims 1
- LAFKUZYWNCHOHT-WHFBIAKZSA-N Ser-Glu Chemical compound OC[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O LAFKUZYWNCHOHT-WHFBIAKZSA-N 0.000 claims 1
- SBMNPABNWKXNBJ-BQBZGAKWSA-N Ser-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CO SBMNPABNWKXNBJ-BQBZGAKWSA-N 0.000 claims 1
- XZKQVQKUZMAADP-IMJSIDKUSA-N Ser-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(O)=O XZKQVQKUZMAADP-IMJSIDKUSA-N 0.000 claims 1
- LDEBVRIURYMKQS-WISUUJSJSA-N Ser-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H](N)CO LDEBVRIURYMKQS-WISUUJSJSA-N 0.000 claims 1
- 108091027967 Small hairpin RNA Proteins 0.000 claims 1
- 108020004459 Small interfering RNA Proteins 0.000 claims 1
- UQTNIFUCMBFWEJ-IWGUZYHVSA-N Thr-Asn Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(O)=O)CC(N)=O UQTNIFUCMBFWEJ-IWGUZYHVSA-N 0.000 claims 1
- IOWJRKAVLALBQB-IWGUZYHVSA-N Thr-Asp Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(O)=O)CC(O)=O IOWJRKAVLALBQB-IWGUZYHVSA-N 0.000 claims 1
- BWUHENPAEMNGQJ-ZDLURKLDSA-N Thr-Gln Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O BWUHENPAEMNGQJ-ZDLURKLDSA-N 0.000 claims 1
- BECPPKYKPSRKCP-ZDLURKLDSA-N Thr-Glu Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O BECPPKYKPSRKCP-ZDLURKLDSA-N 0.000 claims 1
- GXDLGHLJTHMDII-WISUUJSJSA-N Thr-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CO)C(O)=O GXDLGHLJTHMDII-WISUUJSJSA-N 0.000 claims 1
- DSGIVWSDDRDJIO-ZXXMMSQZSA-N Thr-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O DSGIVWSDDRDJIO-ZXXMMSQZSA-N 0.000 claims 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- 235000004279 alanine Nutrition 0.000 claims 1
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 claims 1
- 230000009435 amidation Effects 0.000 claims 1
- 238000007112 amidation reaction Methods 0.000 claims 1
- 239000000427 antigen Substances 0.000 claims 1
- 108091007433 antigens Proteins 0.000 claims 1
- 102000036639 antigens Human genes 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 1
- 108010040443 aspartyl-aspartic acid Proteins 0.000 claims 1
- 108010038633 aspartylglutamate Proteins 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 150000001720 carbohydrates Chemical class 0.000 claims 1
- 235000013477 citrulline Nutrition 0.000 claims 1
- 229960002173 citrulline Drugs 0.000 claims 1
- 239000002872 contrast media Substances 0.000 claims 1
- 230000003247 decreasing effect Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000000975 dye Substances 0.000 claims 1
- 230000032050 esterification Effects 0.000 claims 1
- 238000005886 esterification reaction Methods 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 239000000835 fiber Substances 0.000 claims 1
- 108010063718 gamma-glutamylaspartic acid Proteins 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 238000001476 gene delivery Methods 0.000 claims 1
- 108010055341 glutamyl-glutamic acid Proteins 0.000 claims 1
- 239000003102 growth factor Substances 0.000 claims 1
- 229940088597 hormone Drugs 0.000 claims 1
- 239000005556 hormone Substances 0.000 claims 1
- 238000003384 imaging method Methods 0.000 claims 1
- 239000007943 implant Substances 0.000 claims 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims 1
- 229960000310 isoleucine Drugs 0.000 claims 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- BKGWACHYAMTLAF-BYPYZUCNSA-N l-thiocitrulline Chemical compound OC(=O)[C@@H](N)CCC\N=C(/N)S BKGWACHYAMTLAF-BYPYZUCNSA-N 0.000 claims 1
- 239000003446 ligand Substances 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 claims 1
- 108010054155 lysyllysine Proteins 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 claims 1
- 108020004999 messenger RNA Proteins 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 239000002679 microRNA Substances 0.000 claims 1
- 238000000813 microcontact printing Methods 0.000 claims 1
- 239000011859 microparticle Substances 0.000 claims 1
- 238000000465 moulding Methods 0.000 claims 1
- 239000002105 nanoparticle Substances 0.000 claims 1
- 210000002220 organoid Anatomy 0.000 claims 1
- 244000045947 parasite Species 0.000 claims 1
- 244000052769 pathogen Species 0.000 claims 1
- 239000002798 polar solvent Substances 0.000 claims 1
- 229920001296 polysiloxane Polymers 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 239000000651 prodrug Substances 0.000 claims 1
- 229940002612 prodrug Drugs 0.000 claims 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 239000002096 quantum dot Substances 0.000 claims 1
- 229960002718 selenomethionine Drugs 0.000 claims 1
- 230000035945 sensitivity Effects 0.000 claims 1
- 125000000547 substituted alkyl group Chemical group 0.000 claims 1
- 125000003107 substituted aryl group Chemical group 0.000 claims 1
- 239000000758 substrate Substances 0.000 claims 1
- 229940026510 theanine Drugs 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 239000004474 valine Substances 0.000 claims 1
- 229940088594 vitamin Drugs 0.000 claims 1
- 239000011782 vitamin Substances 0.000 claims 1
- 235000013343 vitamin Nutrition 0.000 claims 1
- 229930003231 vitamin Natural products 0.000 claims 1
- 150000003722 vitamin derivatives Chemical class 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SG2013088919 | 2013-11-30 | ||
| SG201308891-9 | 2013-11-30 | ||
| PCT/SG2014/000569 WO2015080671A1 (en) | 2013-11-30 | 2014-12-01 | Self-assembling peptides, peptidomimetics and peptidic conjugates as building blocks for biofabrication and printing |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017501136A JP2017501136A (ja) | 2017-01-12 |
| JP2017501136A5 true JP2017501136A5 (cg-RX-API-DMAC7.html) | 2017-12-28 |
Family
ID=56101817
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016535121A Pending JP2017501136A (ja) | 2013-11-30 | 2014-12-01 | バイオファブリケーション及びプリンティングのための構成要素としての自己組織化ペプチド、ペプチド模倣体及びペプチド結合体 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10179194B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3074416A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2017501136A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20160091993A (cg-RX-API-DMAC7.html) |
| CN (1) | CN105960411A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2014355214A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112016012128A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2932021A1 (cg-RX-API-DMAC7.html) |
| HK (1) | HK1225745A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2016006990A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2015080671A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9815871B2 (en) | 2013-04-23 | 2017-11-14 | President And Fellows Of Harvard College | Genetic reprogramming of bacterial biofilms |
| CN105960411A (zh) | 2013-11-30 | 2016-09-21 | 新加坡科技研究局 | 自组装肽、肽模拟物和肽缀合物作为构件用于生物制造和打印 |
| EP3074415A4 (en) * | 2013-11-30 | 2017-09-20 | Agency For Science, Technology And Research | Novel ultrashort hydrophobic peptides that self-assemble into nanofibrous hydrogels and their uses |
| CN107406486A (zh) * | 2015-03-31 | 2017-11-28 | 新加坡科技研究局 | 用于生物医学应用的自组装超短脂族环肽 |
| EP3280397A4 (en) | 2015-04-06 | 2018-08-22 | President and Fellows of Harvard College | Biosynthetic amyloid-based materials displaying functional protein sequences |
| US10058502B2 (en) | 2015-12-31 | 2018-08-28 | L'oreal | Nail polish compositions |
| US11098133B2 (en) * | 2016-05-19 | 2021-08-24 | President And Fellows Of Harvard College | Methods of making gels and films using curli nanofibers |
| CN107915848A (zh) * | 2016-10-11 | 2018-04-17 | 中国海洋大学 | 一种甲壳素晶须/羟丁基壳聚糖温敏水凝胶的制备方法 |
| EP3551240A1 (en) * | 2016-12-09 | 2019-10-16 | Biogelx Limited | 3d printing and drug delivery |
| CN106699841B (zh) * | 2017-01-05 | 2020-07-24 | 北京大学深圳研究生院 | 一种自组装的多肽纳米棒及其制备方法 |
| CN106946982B (zh) * | 2017-03-29 | 2020-08-28 | 中国石油大学(华东) | 一种具有抗肿瘤功能的多肽 |
| US11702623B2 (en) | 2017-05-11 | 2023-07-18 | King Abdullah University Of Science And Technology | Device and method for microfluidics-based 3D bioprinting |
| US11472839B2 (en) | 2017-05-11 | 2022-10-18 | King Abdullah University Of Science And Technology | Peptide capable of forming a gel for use in tissue engineering and bioprinting |
| CN111615380B (zh) | 2017-11-07 | 2024-08-23 | 爱尔兰皇家外科医学院 | 用于作为实体瘤癌症的治疗的瘤内给药的热响应性水凝胶 |
| KR102219828B1 (ko) * | 2018-04-11 | 2021-02-24 | 연세대학교 산학협력단 | pH 감응성 펩타이드 구조체, 및 이의 용도 |
| ES2966711T3 (es) | 2018-06-21 | 2024-04-23 | Univ Pittsburgh Commonwealth Sys Higher Education | Hidrogel de matriz extracelular (ECM) como almohadilla líquida submucosa |
| JP2021527518A (ja) * | 2018-06-21 | 2021-10-14 | ユニバーシティ オブ ピッツバーグ − オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション | 食道粘膜下流体クッションとしての膀胱ｅｃｍヒドロゲルの使用 |
| AU2019310647B2 (en) * | 2018-07-24 | 2025-03-06 | Newsouth Innovations Pty Limited | Bio-ink for 3D printing |
| CN109276755B (zh) * | 2018-10-11 | 2021-04-20 | 山东大学齐鲁医院(青岛) | 基于自组装纳米多肽和干细胞的3d打印组织工程血管及其制备方法 |
| ES2754824A1 (es) * | 2018-10-17 | 2020-04-20 | Univ Valladolid | Composicion a base de biopolimeros recombinantes y usos de la misma como biotinta |
| CN109730976B (zh) * | 2018-12-24 | 2020-06-09 | 华中科技大学 | 一种基于自由基氧化制备白蛋白纳米粒的方法 |
| CN110394985B (zh) * | 2019-06-21 | 2021-08-20 | 南京大学 | 一种利用Taylor喷射效应构造双层液锥进行三维连续分子自组装的装置及其方法 |
| KR102228400B1 (ko) * | 2019-09-24 | 2021-03-16 | 고려대학교 산학협력단 | 뇌 오가노이드 제조 방법 |
| WO2021111503A1 (ja) * | 2019-12-02 | 2021-06-10 | 花王株式会社 | 光吸収層及びその製造方法、分散液、光電変換素子、並びに太陽電池 |
| US11559389B2 (en) | 2020-05-05 | 2023-01-24 | International Business Machines Corporation | Bioprinted living tissue with therapy capability |
| CN111840636B (zh) * | 2020-07-30 | 2022-01-18 | 齐鲁工业大学 | 伯氨基暴露量为5％的多肽单层膜及其制备方法与应用 |
| WO2022035778A1 (en) * | 2020-08-10 | 2022-02-17 | Gel4Med, Inc. | Delivery of cells and tissues with self-assembling peptide hydrogel materials |
| US20220056074A1 (en) * | 2020-08-20 | 2022-02-24 | King Abdullah University Of Science And Technology | Peptide compound with repetitive sequences |
| US11673324B2 (en) | 2020-08-20 | 2023-06-13 | King Abdullah University Of Science And Technology | Nozzle for 3D bioprinting |
| US12109327B2 (en) | 2020-08-20 | 2024-10-08 | King Abdullah University Of Science And Technology | Scaffolds from self-assembling tetrapeptides support 3D spreading, osteogenic differentiation and angiogenesis of mesenchymal stem cells |
| WO2022049494A1 (en) * | 2020-09-02 | 2022-03-10 | King Adbullah University Of Science And Technology | Air-loaded gas vesicle nanoparticles for promoting cell growth in 3d bioprinted tissue constructs |
| US12116421B2 (en) | 2020-09-02 | 2024-10-15 | King Abdullah University Of Science And Technology | Peptide-based Dopa containing adhesive gels |
| WO2022084874A1 (en) * | 2020-10-21 | 2022-04-28 | King Adbullah University Of Science And Technology | Delivery of endothelial cell-laden microgel elicits angiogenesis in self-assembling ultrashort peptide hydrogels |
| US11994520B2 (en) | 2020-11-23 | 2024-05-28 | King Abdullah University Of Science And Technology | Developing lateral flow immunochromatography (LFIA) peptide-based test strips for rapid detection of antigens and antibodies against specific antigens |
| CN112263547B (zh) * | 2020-11-26 | 2022-12-20 | 深圳大学 | 一种多功能纳米药物载体及其制备方法与载药组合物 |
| WO2022198231A1 (en) | 2021-03-18 | 2022-09-22 | Seagen Inc. | Selective drug release from internalized conjugates of biologically active compounds |
| CN113321706B (zh) * | 2021-07-15 | 2022-01-07 | 南开大学 | 一种自组装多肽衍生物及其制备的水凝胶 |
| CN115583990B (zh) * | 2022-11-22 | 2023-04-21 | 潍坊医学院 | 一种响应性小分子肽、纳米载药载体及应用 |
| GB2628663A (en) * | 2023-03-31 | 2024-10-02 | Univ Belfast | An injectable delivery system for long-acting administration of drugs |
| WO2024233707A1 (en) * | 2023-05-09 | 2024-11-14 | William Marsh Rice University | 3d printing of self-assembling multidomain peptide hydrogels and fabrication of aligned nanofibrous self-assembling peptide hydrogels |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030175410A1 (en) | 2002-03-18 | 2003-09-18 | Campbell Phil G. | Method and apparatus for preparing biomimetic scaffold |
| EP2203129A4 (en) | 2007-10-15 | 2011-11-23 | Univ Wake Forest Health Sciences | METHOD AND COMPOSITIONS FOR PRINTING BIOCOMPATIBLE NANOROUS COMPOSITES FROM AUTOLOGOUS TISSUE |
| SG184345A1 (en) * | 2010-03-31 | 2012-11-29 | Agency Science Tech & Res | Amphiphilic linear peptide/peptoid and hydrogel comprising the same |
| US8999916B2 (en) * | 2010-03-31 | 2015-04-07 | Agency For Science, Technology And Research | Crosslinked peptide hydrogels |
| SG187271A1 (en) * | 2011-07-07 | 2013-02-28 | Agency Science Tech & Res | Anti-amyloidogenic, alpha-helix breaking ultra-small peptide therapeutic |
| AU2012308715A1 (en) | 2011-09-12 | 2014-04-24 | Organovo, Inc. | Engineered tissues for in vitro research uses, arrays thereof, and methods of making the same |
| WO2013066274A1 (en) * | 2011-11-04 | 2013-05-10 | Agency For Science, Technology And Research | Self-assembled composite ultrasmall peptide-polymer hydrogels |
| SG193042A1 (en) * | 2012-02-22 | 2013-09-30 | Agency Science Tech & Res | Organogels from ultrasmall peptides that can be used for biological and non-biological applications |
| GB201203085D0 (en) | 2012-02-22 | 2012-04-04 | Univ Manchester | Hydrogels |
| US9120841B2 (en) * | 2012-09-28 | 2015-09-01 | Agency For Science, Technology And Research | Amphiphilic linear peptidepeptoid and hydrogel comprising the same |
| WO2014104974A2 (en) * | 2012-12-24 | 2014-07-03 | Agency For Science, Technology And Research | Self-assembling ultrashort peptides modified with bioactive agents by click chemistry |
| SG2012096699A (en) | 2012-12-31 | 2014-07-30 | Agency Science Tech & Res | Amphiphilic linear peptide/peptoid and hydrogel comprising the same |
| EP2958933B1 (en) * | 2013-01-28 | 2018-08-22 | Agency For Science, Technology And Research | Crosslinked peptide hydrogels |
| CN105828838B (zh) * | 2013-10-18 | 2020-03-10 | 新加坡科技研究局 | 含有纳米粒子的水凝胶 |
| EP3074415A4 (en) | 2013-11-30 | 2017-09-20 | Agency For Science, Technology And Research | Novel ultrashort hydrophobic peptides that self-assemble into nanofibrous hydrogels and their uses |
| CN105960411A (zh) | 2013-11-30 | 2016-09-21 | 新加坡科技研究局 | 自组装肽、肽模拟物和肽缀合物作为构件用于生物制造和打印 |
-
2014
- 2014-12-01 CN CN201480073770.7A patent/CN105960411A/zh active Pending
- 2014-12-01 BR BR112016012128A patent/BR112016012128A2/pt not_active IP Right Cessation
- 2014-12-01 US US15/039,952 patent/US10179194B2/en not_active Expired - Fee Related
- 2014-12-01 WO PCT/SG2014/000569 patent/WO2015080671A1/en not_active Ceased
- 2014-12-01 JP JP2016535121A patent/JP2017501136A/ja active Pending
- 2014-12-01 KR KR1020167017328A patent/KR20160091993A/ko not_active Withdrawn
- 2014-12-01 CA CA2932021A patent/CA2932021A1/en not_active Abandoned
- 2014-12-01 MX MX2016006990A patent/MX2016006990A/es unknown
- 2014-12-01 HK HK16114026.1A patent/HK1225745A1/zh unknown
- 2014-12-01 EP EP14866446.9A patent/EP3074416A4/en not_active Withdrawn
- 2014-12-01 AU AU2014355214A patent/AU2014355214A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017501136A5 (cg-RX-API-DMAC7.html) | ||
| Yadav et al. | Short to ultrashort peptide-based hydrogels as a platform for biomedical applications | |
| US10179194B2 (en) | Self-assembling peptides, peptidomimetics and peptidic conjugates as building blocks for biofabrication and printing | |
| US8076295B2 (en) | Peptide amphiphiles having improved solubility and methods of using same | |
| Das et al. | Ultrashort peptides—A glimpse into the structural modifications and their applications as biomaterials | |
| KR102232500B1 (ko) | 암 치료 조성물 및 방법 | |
| Chu et al. | Protein based biomaterials for therapeutic and diagnostic applications | |
| US10953104B2 (en) | Dimeric collagen hybridizing peptides and methods of using | |
| US20180016304A1 (en) | Self-assembling ultrashort aliphatic depsipeptides for biomedical applications | |
| JP2013538864A (ja) | 生物活性アミノ酸配列及びその使用 | |
| Trapani et al. | Peptides and their metal complexes in neurodegenerative diseases: from structural studies to nanomedicine prospects | |
| CN107406486A (zh) | 用于生物医学应用的自组装超短脂族环肽 | |
| TW202140513A (zh) | 人類運鐵蛋白受體結合肽 | |
| US12162959B2 (en) | Cyclic peptide for treating cancer | |
| WO2018106273A1 (en) | Collagen targeting nanofibers and nanosheets | |
| AU2020357455A1 (en) | Molecular guide system peptides and uses thereof | |
| CN115427428B (zh) | 新的细胞穿透肽及其用途 | |
| KR20230088828A (ko) | Cas9-rnp 및 기타 핵단백질 카고의 형질도입을 위해 적합화된 최소 길이의 셔틀제 펩타이드 및 그의 변이체 | |
| Loic | Amino acids modification to improve and fine-tune peptide-based hydrogels | |
| KR20230017713A (ko) | 양친매성 세포 투과성 펩타이드 및 이의 용도 | |
| US11661439B2 (en) | Peptide hydrogels and use thereof | |
| WO2025064985A1 (en) | Myc INHIBITOR PROTEINS AND USES THEREOF | |
| Cirillo | Short cationic peptides for gene delivery into cancer cells | |
| AU2015252036A1 (en) | Methods and compositions for treating CNS injury |